Cordant Inc’s NuVasive, Inc. NUVA Stock Holding History

Cordant Inc’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18	Closed	-$1K	–	1365
2022 Q1	$1K	Buy	+18	New	+$956	﹤0.01%	1184

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cordant Inc's NUVA Position: Q2 2022 in Review

Cordant Inc sold out of NuVasive, Inc. (NUVA) in Q2 2022, closing a stake of 18 shares — an estimated $1K sold.

Cordant Inc first reported a position in NUVA in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 237 funds tracked by Wall St. Rank hold NUVA as of Q2 2022.

Cordant Inc reported no remaining NuVasive, Inc. position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 18 NuVasive, Inc. shares in Q2 2022, an estimated $1K.
Cordant Inc first reported a position in NuVasive, Inc. in Q1 2022 and held it in 1 quarter.
Cordant Inc's NuVasive, Inc. position peaked at $1K in Q1 2022.
237 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.